Michigan VSS #ITN-491-270000000002-1

Michigan newborn hemoglobinopathy testing and result interpretation

Michigan is seeking specialized newborn hemoglobinopathy testing on dried blood spots and interpretation of the results. - Government buyer: Michigan Department of Health and Human Services, Bureau of Laboratories (MDHHS-BOL). - Named organizations: Children’s Hospital Oakland Research Institute (CHORI) is identified as the only provider performing these dried-blood-spot tests and providing the required interpretation; UCSF Benioff Children’s Hospital is also mentioned. - Requested service: Confirmatory testing and result interpretation for newborn screening analytes related to hemoglobinopathies. - Mutation analysis for --SEA/, --FIL/, --THAI/, --MED/, --20.5/, -3.7/, -4.2/, and CS/; Constant Spring; Alpha multiplex ligation-dependent probe amplification (MLPA); Beta sequencing; Beta MLPA; and hereditary persistence of fetal hemoglobin (HPFH). - Quantities and part numbers: None specified; no part numbers apply to the described testing service. - Notable requirement: Testing must be performed on dried blood spots, with interpretation appropriate to newborn hemoglobinopathy screening. - Contract term and value: Not specified.

Description

The Michigan Department of Health and Human Services, Bureau of Laboratories intends to procure confirmatory testing on dried blood spots for specific analytes related to newborn screening for hemoglobinopathies, along with interpretation of results. Testing includes specified hemoglobin mutation analyses, Constant Spring, Alpha and Beta MLPA, Beta sequencing, and testing for hereditary persistence of fetal hemoglobin. The source states that the Childrens Hospital Oakland Research Institute is the only service provider that conducts these tests on dried blood spots and provides the appropriate interpretation.

View original listing